PPT-View from the Nosebleed Section: The Role of Tranexamic Acid in the Management of Epistaxis

Rajeev Shah PharmD RajeevShahrwjbhorg PGY1 Pharmacy Resident Robert Wood Johnson University Hospital Somerset RWJ Barnabas Health 1 Disclosures I Rajeev Shah DO NOT have a financial interestarrangement . Ian Roberts. Tranexamic acid and bleeding. The CRASH-2 trial. Tranexamic acid in traumatic brain injury. Future research . Structure of presentation. Tranexamic acid and bleeding. Activators of . Ghana Emergency Medicine Collaborative. Document Title. : . Evaluation and Management of Epistaxis. Author(s). : . Patrick Carter. . (University of Michigan), 2008. License:. Unless otherwise noted, this material is made available under the terms of the . 1 WHAT IS EPISTAXIS? Epistaxis or nose bleed is the relatively common occurrence of haemorrhage from the nose. It is usually noticed when the blood drains out through the nostrils. It is a common pae Ian Roberts. Tranexamic acid and bleeding. The CRASH-2 trial. Tranexamic acid in traumatic brain injury. Future research . Structure of presentation. Tranexamic acid and bleeding. Activators of . . acid for . I. ntra. C. erebral. . H. aemorrhage. . 2. . (. TICH-2. ). . Adult ≥18 – no upper age limit. Acute spontaneous . intracerebral. . haemorrhage. . Within 8 hours symptom onset. X. March 13, 2018. Christopher J Chin, MD, FRCSC. Rhinology, Anterior Skull Base, Head and Neck Oncology. Otolaryngology- Head & Neck Surgery. Christopher.Chin@Dal.Ca. Epistaxis in 2018. 1. Acknowledgements. Consultant otolaryngologist. . . EPISTAXIS . . Publication Date: January 7, 2020. Disclaimer. This clinical practice guideline is not intended as an exhaustive source of guidance for managing patients with epistaxis. Rather, it is designed to assist clinicians by providing an evidence-based framework for decision-making strategies. The guideline is not intended to replace clinical judgment or establish a protocol for all individuals with this condition and may not provide the only appropriate approach to diagnosing and managing this program of care. As medical knowledge expands, and technology advances, clinical indicators and guidelines are promoted as conditional and provisional proposals of what is recommended under specific conditions but are not absolute. Guidelines are not mandates. These do not and should not purport to be a legal standard of care. The responsible physician, with consideration of all circumstances presented by the individual patient, must determine the appropriate treatment. Adherence to these guidelines will not ensure successful patient outcomes in every situation. The AAO-HNSF emphasizes that these clinical guidelines should not be deemed to include all proper treatment decisions or methods of care, or to exclude other treatment decisions or methods of care reasonably directed to obtaining the same results.. X semestre. Departamento ORL. 2012. Vascularización de las fosas nasales. Irrigación . septum. nasal. A. . esfenopalatina. : 2 ramas-> . A. nasal lateral posterior. A. . septal. posterior.. A. . _1564 554 361 Vol.7; Issue: 3; March 2017 International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249 - 9571 Review Article Diagnosis and Management of Epistaxis: A Summary from Veerle Leenaerts, MDInternal Medicine Resident at AZ Klina, Antwerp Metropolitan Area, Belgium; E-mail: Veerle.Leenaerts2@klina.beNovember 9November 28, 2020 ; , 2020Leenaerts V. Nebulized tranexamic Kareem. Epistaxis. is bleeding from the nose ,could be trivial or life –. threatining. .. Vascular anatomy.. -Arterial . supply,. the. nose is supplied by the following arteries.. 1.Branches of external carotid artery.. in bleeding trauma patients. Here we present the evidence. Bleeding. 45%. CNS . injury. 41%. Organ . failure. 10%. Other. 4%. There are millions of trauma deaths each year. Many patients survive to reach hospital. This slide shows the causes of in-hospital trauma deaths. PATIENTS. . INDICATIONS FOR USE IN TRAUMA.  . Either. SBP <90 mmHg (for patients > 12 years). Or. HR >110 (for patients > 12 years). Neither of the above but still considered to be at risk of significant internal or external haemorrhage (all ages).